Aptamer-Protamine-siRNA nanoparticles in targeted therapy of ErbB3 positive breast cancer cells

Publication date: Available online 9 October 2020Source: International Journal of PharmaceuticsAuthor(s): Xiangshang Xu, Li Li, Xiaolan Li, Deding Tao, Peng Zhang, Jianping Gong

Source: International Journal of Pharmaceutics - October 9, 2020 Category: Drugs & Pharmacology Source Type: research